TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
120 hedge funds and large institutions have $1.76B invested in Turning Point Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 45 increasing their positions, 21 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $230K
Holders
120
Holding in Top 10
4
Calls
–
Puts
$230K
Top Buyers
| 1 | +$88.1M | |
| 2 | +$78.1M | |
| 3 | +$77.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$41M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$22.9M |
Top Sellers
| 1 | -$68.7M | |
| 2 | -$39.4M | |
| 3 | -$12.5M | |
| 4 |
Millennium Management
New York
|
-$12.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.9M |